Brief: Lucira Health Submits EUA For Over-The-Counter Use Of Its Covid-19 & Flu Test
03/01/2023 13:14
Jan 3 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA HEALTH SUBMITS EUA FOR OVER-THE-COUNTER (OTC) USE
OF ITS
COVID-19 & FLU TEST
* LUCIRA HEALTH INC: INTENDS TO MAKE TEST BROADLY AVAILABLE
TO
CONSUMERS BOTH ONLINE AS WELL AS IN PHARMACIES
Source text for Eikon: ID:nGNX6jqYTv
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process